» Articles » PMID: 34592789

CBX8 Interacts with Chromatin PTEN and is Involved in Regulating Mitotic Progression

Overview
Journal Cell Prolif
Date 2021 Sep 30
PMID 34592789
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Besides its role in regulating phosphatidylinositol-3 kinase (PI3K) signalling in the cytosol, PTEN also has a nuclear function. In this study, we attempted to understand the mechanism of chromatin PTEN in suppressing chromosomal instability during cell division.

Materials And Methods: Immunocoprecipitation, ectopic expression, and deletional analyses were used to identify the physical interaction between Chromobox Homolog protein 8 (CBX8) and PTEN, as well as the functional domain(s) of PTEN mediating the interaction. Cell synchronization followed by immunoblotting was employed to study cell cycle regulation of CBX8 and the functional interaction between chromatin PTEN and CBX8. Small interfering RNAs (siRNAs) were used to study the role of PTEN and CBX8 in modulating histone epigenetic markers during the cell cycle.

Results: Polycomb group (PcG) proteins including CBXs function to repress gene expression in a wide range of organisms including mammals. We recently showed that PTEN interacted with CBX8, a component of Polycomb Repressing Complex 1 (PRC1), and that CBX8 co-localized with PTEN in the nucleus. CBX8 levels were high, coinciding with its phosphorylation in mitosis. Phosphorylation of CBX8 was associated with monoubiquitinated PTEN and phosphorylated-BubR1 on chromatin. Moreover, CBX8 played an important role in cell proliferation and mitotic progression. Significantly, downregulation of either PTEN or CBX8 induced H3K27Me3 epigenetic marker in mitotic cells.

Conclusion: CBX8 is a new component that physically interacts with chromatin PTEN, playing an important role in regulating mitotic progression.

Citing Articles

Enzyme-independent role of EZH2 in regulating cell cycle progression via the SKP2-KIP/CIP pathway.

Colon T, Kou Z, Choi B, Tran F, Zheng E, Dai W Sci Rep. 2024; 14(1):13389.

PMID: 38862595 PMC: 11166936. DOI: 10.1038/s41598-024-64338-4.


High CBX8 Expression Leads to Poor Prognosis in Laryngeal Squamous Cell Carcinoma by Inducing EMT by Activating the Wnt/β-Catenin Signaling Pathway.

Meng Q, Li L, Wang L Front Oncol. 2022; 12:881262.

PMID: 35814427 PMC: 9259798. DOI: 10.3389/fonc.2022.881262.


Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.

Lin J, Chen L, Wu D, Lin J, Liu B, Guo C Comput Math Methods Med. 2022; 2022:1372879.

PMID: 35813444 PMC: 9259361. DOI: 10.1155/2022/1372879.


CBX8 interacts with chromatin PTEN and is involved in regulating mitotic progression.

Choi B, Colon T, Lee E, Kou Z, Dai W Cell Prolif. 2021; 54(11):e13110.

PMID: 34592789 PMC: 8560621. DOI: 10.1111/cpr.13110.

References
1.
Sun H, Lesche R, Li D, Liliental J, Zhang H, Gao J . PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A. 1999; 96(11):6199-204. PMC: 26859. DOI: 10.1073/pnas.96.11.6199. View

2.
Henriquez B, Bustos F, Aguilar R, Becerra A, Simon F, Montecino M . Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons. Mol Cell Neurosci. 2013; 57:130-43. DOI: 10.1016/j.mcn.2013.07.012. View

3.
Zhang C, Chen S, Wang C, He Y, Yang X, Xie D . CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma. Cancer Res. 2017; 78(1):51-63. DOI: 10.1158/0008-5472.CAN-17-0700. View

4.
Yang Y, Duan Q, Guo T, Wang X, Ruan Q, Xu G . BubR1 deficiency results in enhanced activation of MEK and ERKs upon microtubule stresses. Cell Prolif. 2007; 40(3):397-410. PMC: 6495970. DOI: 10.1111/j.1365-2184.2007.00443.x. View

5.
Tavares L, Dimitrova E, Oxley D, Webster J, Poot R, Demmers J . RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell. 2012; 148(4):664-78. PMC: 3281992. DOI: 10.1016/j.cell.2011.12.029. View